Sustainability in the Pharmaceutical Industry
The pharmaceutical industry significantly impacts the environment due to the generation of hazardous waste, the use of energy and water, and the emission of greenhouse gases. [...]
World AIDS Day
World AIDS Day, commemorated on December 1 of each year, is dedicated to publicizing the global AIDS epidemic caused by the spread of HIV infection. [...]
Estudios clínicos para parches transdérmicos genéricos: bioequivalencia, adhesión y seguridad cutánea
Los requisitos clínicos para la aprobación de un parche transdérmico genérico son sustancialmente más exigentes que los de las formas orales convencionales. Un comprimido genérico típicamente necesita demostrar bioequivalencia farmacocinética en un único estudio cruzado. Un parche genérico requiere demostrar bioequivalencia bajo esquemas de dosis única y múltiple, no-inferioridad estadística en adhesión, [...]
World Mental Health Day
October 10 marks World Mental Health Day. This is an opportunity to talk about mental health in general, how we should take care of it, and how important it is to get help if you're struggling. [...]
New methylphenidate transdermal patch for Attention Deficit of Hyperactivity Disorder (ADHD)
In October, we join to the awareness campaigns on ADHD by sharing this article that briefly describes the characteristics of transdermal system containing methylphenidate that has been recently developed by Amarin Technologies for the treatment of this condition. [...]
The times of the industry
The arrival of a drug on the market has many challenges. [...]
Novartis’ Ballet
Exelon® should be featured in pharmaceutical marketing courses as one of the best success stories when it comes to life cycle management. In the following article, we tell the reasons [...]
Big data and pharma
The use of new tools to explore Big Data sets has accelerated their use in the field of health. [...]
Estrategia de out-licensing de CDMO farmacéutico: cómo Amarin Technologies construyó presencia global desde Argentina
Amarin Technologies opera como un CDMO farmacéutico con estrategia de out-licensing en uno de los entornos operativos más desafiantes del mundo, Argentina. Para los socios potenciales que evalúan un CDMO para desarrollo transdermal, licenciamiento o acuerdos de suministro comercial, el contexto argentino es o bien una preocupación o, examinado de cerca, evidencia de [...]
API characteristics for Transdermal Drug Delivery Systems
In order for an IFA to be administered through the skin, it must meet certain characteristics. [...]